of her research team has been elucidation of the role of eicosanoids in neoplasia, they have also shown that reactive oxygen species and cytokines are important contributors to carcinogenesis. Generating and using genetically engineered mouse models, her team showed that COX-2, but not COX-1, is required for ultraviolet light induced skin cancer. Further studies demonstrated that COX-2-induced prostaglandin synthesis has tumor promoting activity via the same signaling pathways activated by phorbol ester tumor promoters. Dr. Fischer's team also demonstrated that overexpression of COX-2 in the pancreas causes spontaneous pancreatitis that progresses to pancreatic ductal adenocarcinoma, establishing a new mouse model for the disease. In recent years, her laboratory has focused on two areas, elucidating the contribution of each of the four EP receptors for prostaglandin E 2 to skin cancer and understanding the molecular mechanisms behind the demonstration by her laboratory, in collaboration with Dr. Steve Hursting, that calorie restriction inhibits, while obesity exacerbates, pancreatitis and pancreatic cancer. These finding s offer new strategies, targets, and opportunities for cancer prevention.
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